Compare NVAX & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVAX | UVE |
|---|---|---|
| Founded | 1987 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1996 | 1996 |
| Metric | NVAX | UVE |
|---|---|---|
| Price | $10.00 | $44.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $11.33 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 5.3M | 118.2K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.97% |
| EPS Growth | ★ 309.76 | 214.43 |
| EPS | N/A | ★ 3.93 |
| Revenue | $1,123,479,000.00 | ★ $1,603,915,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.88 |
| P/E Ratio | ★ N/A | $11.17 |
| Revenue Growth | ★ 64.69 | 5.48 |
| 52 Week Low | $6.20 | $24.50 |
| 52 Week High | $11.85 | $45.15 |
| Indicator | NVAX | UVE |
|---|---|---|
| Relative Strength Index (RSI) | 52.31 | 53.36 |
| Support Level | $9.14 | $41.80 |
| Resistance Level | $10.10 | $45.13 |
| Average True Range (ATR) | 0.58 | 0.91 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 23.66 | 53.60 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.